通过收购基因泰克，罗氏已经在其贫血症研究方面，增加了抗癌药和其他潜在有利可图的、有前景的治疗方法。
By taking over Genentech, Roche has added promising drugs for cancer and other potentially lucrative treatments to its otherwise anaemic research pipeline.
紧接着，瑞典罗氏药厂决定放弃此前对加利福利亚生物制药业领头羊基因泰科公司提出的温和收购方案，转之对其进行恶意收购。
Soon afterwards Switzerland’s Roche decided to abandon its previously friendly overtures toward Genentech, a Californian biotechnology pioneer, in favour of a hostile takeover bid.
NHS提供PGD技术已经超过10年时间了，用来治疗一些早在儿童时期发病的严重疾病，例如囊性纤维化(属遗传性胰腺病)或者叫泰萨氏病的一种神经学疾病。
PGD has been offered by the NHS for more than a decade for serious diseases that come early in childhood, like cystic fibrosis or Tay Sachs, a neurological disease.
应用推荐